Literature DB >> 30232458

T cells in patients with narcolepsy target self-antigens of hypocretin neurons.

Daniela Latorre1,2, Ulf Kallweit3,4, Eric Armentani1, Mathilde Foglierini1,5, Federico Mele1, Antonino Cassotta1,2, Sandra Jovic1, David Jarrossay1, Johannes Mathis3, Francesco Zellini6, Burkhard Becher7, Antonio Lanzavecchia1, Ramin Khatami8, Mauro Manconi3,6, Mehdi Tafti9, Claudio L Bassetti10, Federica Sallusto11,12.   

Abstract

Narcolepsy is a chronic sleep disorder caused by the loss of neurons that produce hypocretin. The close association with HLA-DQB1*06:02, evidence for immune dysregulation and increased incidence upon influenza vaccination together suggest that this disorder has an autoimmune origin. However, there is little evidence of autoreactive lymphocytes in patients with narcolepsy. Here we used sensitive cellular screens and detected hypocretin-specific CD4+ T cells in all 19 patients that we tested; T cells specific for tribbles homologue 2-another self-antigen of hypocretin neurons-were found in 8 out of 13 patients. Autoreactive CD4+ T cells were polyclonal, targeted multiple epitopes, were restricted primarily by HLA-DR and did not cross-react with influenza antigens. Hypocretin-specific CD8+ T cells were also detected in the blood and cerebrospinal fluid of several patients with narcolepsy. Autoreactive clonotypes were serially detected in the blood of the same-and even of different-patients, but not in healthy control individuals. These findings solidify the autoimmune aetiology of narcolepsy and provide a basis for rapid diagnosis and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30232458     DOI: 10.1038/s41586-018-0540-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

Review 1.  Narcolepsy.

Authors:  Thomas E Scammell
Journal:  N Engl J Med       Date:  2015-12-31       Impact factor: 91.245

Review 2.  Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination.

Authors:  Markku Partinen; Birgitte Rahbek Kornum; Giuseppe Plazzi; Poul Jennum; Ilkka Julkunen; Outi Vaarala
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

3.  DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.

Authors:  Mehdi Tafti; Hyun Hor; Yves Dauvilliers; Gert J Lammers; Sebastiaan Overeem; Geert Mayer; Sirous Javidi; Alex Iranzo; Joan Santamaria; Rosa Peraita-Adrados; José L Vicario; Isabelle Arnulf; Giuseppe Plazzi; Sophie Bayard; Francesca Poli; Fabio Pizza; Peter Geisler; Aleksandra Wierzbicka; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Claire E H M Donjacour; Astrid van der Heide; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Birgit Högl; Birgit Frauscher; Antonio Benetó; Ramin Khatami; Francesca Cañellas; Corinne Pfister; Sabine Scholz; Michel Billiard; Christian R Baumann; Guadalupe Ercilla; Willem Verduijn; Frans H J Claas; Valérie Dubois; Jacek Nowak; Hans-Peter Eberhard; Sylvain Pradervand; Charlotte N Hor; Manuela Testi; Jean-Marie Tiercy; Zoltán Kutalik
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

4.  Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Christelle Monaca Charley; Patricia Franco; Xavier Drouot; Marie-Pia d'Ortho; Sandrine Launois; Séverine Lignot; Patrice Bourgin; Béatrice Nogues; Marc Rey; Sophie Bayard; Sabine Scholz; Sophie Lavault; Pascale Tubert-Bitter; Cristel Saussier; Antoine Pariente
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

5.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

6.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

Review 7.  Narcolepsy with cataplexy.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Emmanuel Mignot
Journal:  Lancet       Date:  2007-02-10       Impact factor: 79.321

8.  Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.

Authors:  Michel Lecendreux; Guillaume Churlaud; Fabien Pitoiset; Armelle Regnault; Tu Anh Tran; Roland Liblau; David Klatzmann; Michelle Rosenzwajg
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

9.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

10.  High-dimensional single-cell analysis reveals the immune signature of narcolepsy.

Authors:  Felix J Hartmann; Raphaël Bernard-Valnet; Clémence Quériault; Dunja Mrdjen; Lukas M Weber; Edoardo Galli; Carsten Krieg; Mark D Robinson; Xuan-Hung Nguyen; Yves Dauvilliers; Roland S Liblau; Burkhard Becher
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

View more
  69 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  T cells fingered as culprits for narcolepsy.

Authors:  Barbara Nasto
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

3.  Narcolepsy risk and COVID-19.

Authors:  Emmanuel Mignot; Steve Black
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

Review 4.  [Composition and mode of action of adjuvants in licensed viral vaccines].

Authors:  Ralf Wagner; Eberhard Hildt
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

Review 5.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

6.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Authors:  Cecilia S Lindestam Arlehamn; John Pham; Roy N Alcalay; April Frazier; Evan Shorr; Chelsea Carpenter; John Sidney; Rekha Dhanwani; Julian Agin-Liebes; Francesca Garretti; Amy W Amara; David G Standaert; Elizabeth J Phillips; Simon A Mallal; Bjoern Peters; David Sulzer; Alessandro Sette
Journal:  J Immunol       Date:  2019-05-13       Impact factor: 5.422

Review 7.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

Review 8.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

9.  Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future.

Authors:  Ryan K Tisdale; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Sleep       Date:  2021-06-11       Impact factor: 5.849

10.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.